Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VENUSREM.NSthis companyVenus Remedies Limited	₹1,448.30	10.67×	1.65×	1.42×	6.74×	-14.2%	34.8%	15.8%	13.4%	15.5%	13.4%	10.9%	0.02×	-0.11×	3,040.25×	2.44×	0.0%	4	9.87	4	A-
ALBERTDAVD.NSAlbert David Limited	₹800.90	-224.06×	0.86×	1×	25.69×	-34.8%	32.2%	-1.3%	-0.4%	-0.4%	2.8%	-10.5%	0.08×	-0.24×	-1.63×	3.24×	0.9%	2	—	2	C+
ININDSWFTLAB.BOInd-Swift Laboratories Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
INDSWFTLAB.NSInd-Swift Laboratories Limited	₹349.05	26.55×	0.79×	1.71×	15.31×	-42.2%	29.7%	2.3%	6.5%	3.0%	0.9%	-9.8%	0.01×	-9.08×	10.31×	3.8×	0.0%	2	7.26	3	B
JENBURPH.BOJenburkt Pharmaceuticals Limited	₹959.75	12.14×	2.14×	2.5×	8.36×	76.8%	49.4%	24.1%	20.6%	17.6%	14.9%	3.9%	0.01×	-0.06×	87.95×	4.11×	1.9%	2	—	3	B
KIKILITCH.BOKilitch Drugs (India) Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	12.14×	0.86×	1.71×	15.31×	-34.8%	32.2%	2.3%	6.5%	3.0%	2.8%	-9.8%	0.01×	-0.24×	10.31×	3.8×	0.9%	2	7.26	3	—